The soaring cost of prescription drugs has ignited public pressure for action. Governments are considering aggressive price controls as a solution, promising relief at the pharmacy counter. But behind the headlines lies a potential storm: mass layoffs in the pharma industry.
The domino effect:
1. Squeezing profits: Imagine price ceilings imposed on essential drugs. Profits dwindle, forcing companies to prioritize. Research and development (R&D) — an innovation engine — is often the first casualty.
2. Innovation on hold: With R&D budgets slashed, the pipeline of new drugs shrinks. Imagine a future with fewer breakthroughs for chronic diseases, Alzheimer’s, or cancer. The human cost of stagnant innovation is immeasurable.